Graves disease: Clinical features and treatment results;Morbus basedow: Klinik und behandlungsergebnisse

Acta Medica Austriaca

Volumn 28, Issue 2, 2001, Pages 47-51

  Crivellaro, C ^a   Oberhofer, R ^a   Leimgruber, K ^a   Amor, H ^a  

^a Regionalkrankenhaus Bozen   (Italy)

Author keywords

Clinical signs; Grave's disease; Hyperthyroidism; Treatment

Indexed keywords

ANTITHYROID AGENT; RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; DOSE RESPONSE; FEMALE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; RADIOISOTOPE THERAPY; REMISSION; SKIN SURFACE; TACHYCARDIA; TREATMENT OUTCOME; WEIGHT REDUCTION;

ANTITHYROID AGENTS; DISEASE-FREE SURVIVAL; FEMALE; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; MALE; RECURRENCE; RETROSPECTIVE STUDIES; SWEATING; TACHYCARDIA; THYROIDECTOMY; THYROXINE; TREMOR; TRIIODOTHYRONINE; WEIGHT LOSS;

EID: 0035041903     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1563-2571.2001.01011.x     Document Type: Article

References (26)

1. Age and gender predict the outcome of treatment for Graves' hyperthyroidism
2. Antithyroid drugs and Grave's disease: A prospective randomized evaluation of the efficacy of treatment duration
3. Thyroid vascularization by color doppler ultrasonography in Grave's disease. Changes related to different phases and to the long-term outcome of the disease
4. Is there a methimazole dose effect on remission rate in Grave's disease? Results from a long-term prospective study
5. Farbkodierte doppler sonographie zur differenzierung der hyperthyreose
6. Outcome of treatment of hyperthyroidism
7. Klinik, diagnostik und medikamentöse therapie der hyperthyreose
8. Evaluation of serum basal thyrotrophin levels and thyrotropin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Grave's disease
9. Die behandlung der hyperthyreose mit antithyreoidalen substanzen
10. The many "faces" of Grave's disease, Part 1
11. Antithyroid drug and Grave's hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission
12. High versus low doses of carbimazole in the treatment of Grave's disease
13. Quality of life aspects and costs in treatment of Grave's hyperthyroidism with antithyroid drugs, surgery or radioiodine: Results from a prospective, randomized study
14. Antithyroid drugs and Grave's disease-prospective randomized assessment of long-term treatment
15. Probleme der medikamentösen therapie des morbus basedow
16. Postoperative komplikationen und langzeitergebnisse der chirurgischen therapie der immunthyreopathie vom typ basedow
17. Schilddrüsenvolumen gesunder erwachsener in einem strumaendemiegebiet
18. Treatment of Grave's hyperthyroidism with radioiodine: Results of a prospective randomized study
19. A prospective randomized trial of antithyroid drug dose in Grave's disease
20. Individual outcome monitoring of TSH receptor antibody level for predicting the prognosis of Grave's disease
21. Hyperthyreose typ Mb. basedow - Gibt es einen therapeutischen standard? Konservative therapie
22. Hyperthyreose typ morbus basedow - Medikamentöse therapie
23. Thionamide therapy in Grave's disease: Relation of relapse rate to duration of therapy
24. Grave's hyperthyroidism: Treatment with antithyroid drugs, surgery or radioiodine - A prospective, randomized study
25. Doppler ultrasonography in predicting relapse of hyperthyroidism in Grave's disease
26. Clinical features of patients with Grave's disease undergoing remission after antithyroid drug treatment